Neurocrine Biosciences total liabilities and share holders equity for the quarter ending September 30, 2024 was $3.535B, a 24.11% increase year-over-year.
Neurocrine Biosciences total liabilities and share holders equity for 2023 was $3.251B, a 37.27% increase from 2022.
Neurocrine Biosciences total liabilities and share holders equity for 2022 was $2.369B, a 14.29% increase from 2021.
Neurocrine Biosciences total liabilities and share holders equity for 2021 was $2.073B, a 19.47% increase from 2020.
Neurocrine Biosciences Total Liabilities and Share Holders Equity 2010-2024 | NBIX